Advertisement

Gender Differences in Adolescent Opioid Misuse and Major Depressive Episodes

  • Keith Tsz-Kit ChanEmail author
  • Christina Marsack-Topolewski
Article
  • 26 Downloads

Abstract

The opioid crisis is a public health emergency in the United States, with staggering financial and social costs to society. Nonmedical prescription opioid use (NMPOU) disproportionately impacts adolescents, with opioid-related mortality rates increasing for female adolescents. Past research has linked opioid misuse to mental health problems, and adolescents have the highest prevalence of substance use and mental health disorders compared with other age cohorts. This study examined the relationship of adolescent NMPOU with having a major depressive episode (MDE), stratified by gender. This study used data from the 2016 National Survey on Drug Use and Health (NSDUH), and included 11,489 respondents aged 12 to 17. Multivariate logistic regression analyses using survey design weights were used to examine the effect of past-year NMPOU with the odds of having a past-year major depressive episode. Results indicated a higher prevalence of past-year MDE among adolescents who used NMPOU (34.0%), compared to those who did not (12.7%). Adolescent opioid misuse was associated with increased 60% higher odds for having a past-year MDE (OR = 1.60, 95% CI [1.11, 2.32], p < 0.05). Subgroup analysis found that NMPOU was associated with increased odds for having a past-year MDE for adolescent females (OR = 1.99, 95% CI [1.24, 3.17], p < 0.01), while the association of NMPOU with past-year MDE was not statistically observed for adolescent males. Results indicated that opioid misuse is a leading factor associated with having a major depressive episode among adolescent females. Adolescent females were at a higher risk for poor mental health outcomes compared to adolescent males. Social workers in collaboration with other professionals can play a central role by coordinating substance use and mental health prevention and recovery services.

Keywords

Opioids Adolescent females Depression 

Notes

Funding

This study did not have any external funding.

Compliance with Ethical Standards

Research Involved in Human or Animal Rights

This article does not contain any studies with human participants performed by any of the authors.

References

  1. Abraham, O., Thakur, T., & Brown, R. (2019). Prescription opioid misuse and the need to promote medication safety among adolescents. Research in Social and Administrative Pharmacy.  https://doi.org/10.1016/j.sapharm.2019.01.003.CrossRefPubMedGoogle Scholar
  2. Alati, R., Dunn, N., Purdie, D. M., Roche, A. M., Dennerstein, L., Darlington, S. J., …, Green, A. C. (2007). Moderate alcohol consumption contributes to women’s well-being through the menopausal transition. Climacteric, 10, 491–499.  https://doi.org/10.1080/13697130701739118.CrossRefGoogle Scholar
  3. Al-Tayyib, A., Riggs, P., Mikulich-Gilbertson, S., & Hopfer, C. (2018). Prevalence of nonmedical use of prescription opioids and association with co-occurring substance use disorders among adolescents in substance use treatment. Journal of Adolescent Health, 62, 241–244.  https://doi.org/10.1016/j.jadohealth.2017.09.018.CrossRefPubMedGoogle Scholar
  4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.Google Scholar
  5. Becker, W. C., Fiellin, D. A., & Desai, R. A. (2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates. Drug and Alcohol Dependence, 90, 280–287.  https://doi.org/10.1016/j.drugalcdep.2007.04.009.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bellos, S., Skapinakis, P., Rai, D., Zitko, P., Araya, R., Lewis, G., …, Mavreas, V. (2013). Cross-cultural patterns of the association between varying levels of alcohol consumption and the common mental disorders of depression and anxiety: Secondary analysis of the WHO collaborative study on psychological problems in general health care. Drug and Alcohol Dependence, 133, 825–831.  https://doi.org/10.1016/j.drugalcdep.2013.08.030.CrossRefGoogle Scholar
  7. Bewley, T. H., Ben-Arie, O., & James, I. P. (1968). Morbidity and mortality from heroin dependence: Survey of heroin addicts known to home office. British Medical Journal, 1, 725–726.  https://doi.org/10.1136/bmj.1.5594.725.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Brownlie, E., Beitchman, J. H., Chaim, G., Wolfe, D. A., Rush, B., & Henderson, J. (2019). Early adolescent substance use and mental health problems and service utilisation in a school-based sample. The Canadian Journal of Psychiatry, 64, 116–125.  https://doi.org/10.1177/0706743718784935.CrossRefPubMedGoogle Scholar
  9. Cairney, S., O’Connor, N., Dingwall, K. M., Maruff, P., Shafiq-Antonacci, R., Currie, J., & Currie, B. J. (2013). A prospective study of neurocognitive changes 15 years after chronic inhalant abuse. Addiction, 108, 1107–1114.  https://doi.org/10.1111/add.12124.CrossRefPubMedGoogle Scholar
  10. Center for Behavioral Health Statistics and Quality. (2016a). 2015 National Survey on Drug Use and Health: Methodological summary and definitions. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-MethodSummDefsHTML-2015/NSDUH-MethodSummDefsHTML-2015/NSDUH-MethodSummDefs-2015.htm.
  11. Center for Behavioral Health Statistics and Quality. (2016b). 2015 National Survey on Drug Use and Health: Public use file codebook. Retrieved from http://samhda.s3-us-gov-west-1.amazonaws.com/s3fs-public/field-uploads-protected/studies/NSDUH-2015/NSDUH-2015-datasets/NSDUH-2015-DS0001/NSDUH-2015-DS0001-info/NSDUH-2015-DS0001-info-codebook.pdf.
  12. Center for Behavioral Health Statistics and Quality. (2018). 2017 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD. Retrieved from https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf.
  13. Centers for Disease Control and Prevention. (2017). Opioid overdose. Retrieved from https://www.cdc.gov/drugoverdose/data/heroin.html.
  14. Chen, P., & Jacobson, K. C. (2012). Developmental trajectories of substance use from early adolescence to young adulthood: Gender and racial/ethnic differences. Journal of Adolescent Health, 50, 154–163.  https://doi.org/10.1016/j.jadohealth.2011.05.013.CrossRefPubMedGoogle Scholar
  15. Cheng, T. C., & Lo, C. C. (2017). Social risk and protective factors in adolescents’ reduction and cessation of alcohol use. Substance Use and Misuse, 52, 916–928.  https://doi.org/10.1080/10826084.2016.1267220.CrossRefPubMedGoogle Scholar
  16. Chung, C. P., Callahan, S. T., Cooper, W. O., Dupont, W. D., Murray, K. T., Franklin, A. D., …, Ray, W. A. (2018). Outpatient opioid prescriptions for children and opioid-related adverse events. Pediatrics, 142, e20172156.  https://doi.org/10.1542/peds.2017-2156.CrossRefGoogle Scholar
  17. Coben, J. H., Davis, S. M., Furbee, P. M., Sikora, R. D., Tillotson, R. D., & Bossarte, R. M. (2010). Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. American Journal of Preventive Medicine, 38, 517–524.  https://doi.org/10.1016/j.amepre.2010.01.022.CrossRefPubMedGoogle Scholar
  18. Collishaw, S. (2015). Annual research review: Secular trends in child and adolescent mental health. Journal of Child Psychology and Psychiatry, 56, 370–393.  https://doi.org/10.1111/jcpp.12372.CrossRefPubMedGoogle Scholar
  19. Crossin, R., Cairney, S., Lawrence, A. J., & Duncan, J. R. (2017). Adolescent inhalant abuse leads to other drug use and impaired growth: Implications for diagnosis. Australian and New Zealand Journal of Public Health, 41, 99–104.  https://doi.org/10.1111/1753-6405.12595.CrossRefPubMedGoogle Scholar
  20. Curtin, S. C., Tejada-Vera, B., & Warner, M. (2017). Drug overdose deaths among adolescents aged 15–19 in the United States: 1999–2015. NCHS Data Brief. Number 282. National Center for Health Statistics. Retrieved from https://files.eric.ed.gov/fulltext/ED575708.pdf.
  21. Edlund, M. J., Forman-Hoffman, V. L., Winder, C. R., Heller, D. C., Kroutil, L. A., Lipari, R. N., & Colpe, L. J. (2015). Opioid abuse and depression in adolescents: Results from the National Survey on Drug Use and Health. Drug and Alcohol Dependence, 152, 131–138.  https://doi.org/10.1016/j.drugalcdep.2015.04.010.CrossRefPubMedGoogle Scholar
  22. Fischer, B., Lusted, A., Roerecke, M., Taylor, B., & Rehm, J. (2012). The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: A systematic review and meta-analysis. Journal of Pain, 13, 1029–1044.  https://doi.org/10.1016/j.jpain.2012.07.013.CrossRefPubMedGoogle Scholar
  23. Fortuna, R. J., Robbins, B. W., Caiola, E., Joynt, M., & Halterman, J. S. (2010). Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics, 6, 1108–1116.  https://doi.org/10.1542/peds.2010-0791.CrossRefGoogle Scholar
  24. Grella, C. E., & Lovinger, K. (2012). Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addictive Behaviors, 37, 306–312.  https://doi.org/10.1016/j.addbeh.2011.11.028.CrossRefPubMedGoogle Scholar
  25. Griesler, P. C., Hu, M. C., Wall, M. M., & Kandel, D. B. (2019). Nonmedical prescription opioid use by parents and adolescents in the US. Pediatrics, 143, 1–10.  https://doi.org/10.1542/peds.2018-2354.CrossRefGoogle Scholar
  26. Harbaugh, C. M., Lee, J. S., Hu, H. M., McCabe, S. E., Voepel-Lewis, T., Englesbe, M. J., …, Waljee, J. F. (2018). Persistent opioid use among pediatric patients after surgery. Pediatrics, 141, e20172439.  https://doi.org/10.1001/jama.2018.9023.CrossRefGoogle Scholar
  27. Harbaugh, C. M., Nalliah, R. P., Hu, H. M., Englesbe, M. J., Waljee, J. F., & Brummett, C. M. (2018b). Persistent opioid use after wisdom tooth extraction. JAMA, 320, 504–506.  https://doi.org/10.1542/peds.2017-2439.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Hoff, A. L., Riordan, H., Morris, L., Cestaro, V., Wieneke, M., Alpert, R., …, Volkow, N. (1996). Effects of crack cocaine on neurocognitive function. Psychiatry Research, 60, 167–176.  https://doi.org/10.1016/0165-1781(96)02758-8.CrossRefGoogle Scholar
  29. King, N. B., Fraser, V., Boikos, C., Richardson, R., & Harper, S. (2014). Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: A systematic review. American Journal of Public Health, 104, e32–e42.  https://doi.org/10.2105/AJPH.2014.301966.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Larach, D. B., Waljee, J. F., Hu, H. M., Lee, J. S., Nalliah, R., Englesbe, M. J., & Brummett, C. M. (2019). Patterns of initial opioid prescribing to opioid-naive patients. Annals of Surgery.  https://doi.org/10.1097/SLA.0000000000002969.CrossRefPubMedGoogle Scholar
  31. Lévesque, A., Roy, E., Jutras-Aswad, D., Zang, G., Artenie, A. A., & Bruneau, J. (2016). Examining the link between psychological distress, mental health disorders and sharing behaviors among cocaine users. Addictive Behaviors, 62, 54–59.  https://doi.org/10.1016/j.addbeh.2016.06.004.CrossRefPubMedGoogle Scholar
  32. Malbergier, A., Cardoso, L. D., Abrantes do Amaral, R., & Santos, V. V. (2012). Gender parity and drug use: are girls catching up with boys? Revista Brasileira De Psiquiatria, 34, 16–23.  https://doi.org/10.1590/S1516-44462012000100005.CrossRefPubMedGoogle Scholar
  33. McCabe, S. E., Veliz, P. T., Boyd, C. J., Schepis, T. S., McCabe, V. V., & Schulenberg, J. E. (2019). A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife. Drug and Alcohol Dependence, 194, 377–385.  https://doi.org/10.1016/j.drugalcdep.2018.10.027.CrossRefPubMedGoogle Scholar
  34. McCabe, S. E., Veliz, P., Wilens, T. E., West, B. T., Schepis, T. S., Ford, J. A., …, Boyd, C. J. (2019). Sources of nonmedical prescription drug misuse among US high school seniors: Differences in motives and substance use behaviors. Journal of the American Academy of Child & Adolescent Psychiatry, 58, 681-691.  https://doi.org/10.1016/j.jaac.2018.11.018.CrossRefGoogle Scholar
  35. McCabe, S. E., West, B. T., Veliz, P., McCabe, V. V., Stoddard, S. A., & Boyd, C. J. (2017). Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976–2015. Pediatrics, 139, e20162387.  https://doi.org/10.1542/peds.2016-2387.CrossRefPubMedPubMedCentralGoogle Scholar
  36. McCabe, S. E., Wilens, T. E., Boyd, C. J., Chua, K., Voepel-Lewis, T., & Schepis, T. S. (2019). Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States. Addictive Behaviors, 90, 285–293.  https://doi.org/10.1016/j.addbeh.2018.11.010.CrossRefPubMedGoogle Scholar
  37. Meier, M. H., Hill, M. L., Small, P. J., & Luthar, S. S. (2015). Associations of adolescent cannabis use with academic performance and mental health: A longitudinal study of upper middle class youth. Drug and Alcohol Dependence, 156, 207–212.  https://doi.org/10.1016/j.drugalcdep.2015.09.010.CrossRefPubMedPubMedCentralGoogle Scholar
  38. Miech, R., Johnston, L., O’Malley, P. M., Keyes, K. M., & Heard, K. (2015). Prescription opioids in adolescence and future opioid misuse. Pediatrics, 136, e1169–e1177.  https://doi.org/10.1542/peds.2015-1364.CrossRefPubMedPubMedCentralGoogle Scholar
  39. Minnes, S., Min, M. O., Singer, L. T., Edguer, M., Wu, M., & Thi, P. (2012). Cocaine use during pregnancy and health outcome after 10 years. Drug and Alcohol Dependence, 126, 71–79.  https://doi.org/10.1016/j.drugalcdep.2012.04.015.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Miron, O., Yu, K., Wilf-Miron, R., & Kohane, I. S. (2019). Suicide rates among adolescents and young adults in the United States, 2000-2017. JAMA, 321, 2362–2364.  https://doi.org/10.1001/jama.2019.5054.CrossRefPubMedGoogle Scholar
  41. Mojtabai, R. (2018). National trends in long-term use of prescription opioids. Pharmacoepidemiology and Drug Safety, 27(5), 526–534.  https://doi.org/10.1002/pds.4278.CrossRefPubMedGoogle Scholar
  42. Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics.  https://doi.org/10.1542/peds.2016-1878.CrossRefPubMedPubMedCentralGoogle Scholar
  43. National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press.  https://doi.org/10.17226/24625.CrossRefGoogle Scholar
  44. Perou, R., Bitsko, R. H., Blumberg, S. J., Pastor, P., Ghandour, R. M., Gfroerer, J. C. et al. (2013). Mental health surveillance among children—United States, 2005–2011. Morbidity and Mortality Weekly Report (MMWR) Suppl., 62, 1–35. Atlanta, GA: Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/su6202a1.htm.
  45. Power, C., Rodgers, B., & Hope, S. (1998). U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality. The Lancet, 352, 877.  https://doi.org/10.1016/S0140-6736(98)23937-7.CrossRefGoogle Scholar
  46. Powers, J., Duffy, L., Burns, L., & Loxton, D. (2016). Binge drinking and subsequent depressive symptoms in young women in Australia. Drug and Alcohol Dependence, 161, 86–94.  https://doi.org/10.1016/j.drugalcdep.2016.01.019.CrossRefPubMedGoogle Scholar
  47. President’s Commission on Combatting Drug Addiction and the Opioid Crisis. (2017). Commission interim report. Retrieved from https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Final_Report_Draft_111-2017.pdf.
  48. Quinn, K., Frueh, B. C., Scheidell, J., Schatz, D., Scanlon, F., & Khan, M. R. (2019). Internalizing and externalizing factors on the pathway from adverse experiences in childhood to non-medical prescription opioid use in adulthood. Drug and Alcohol Dependence, 197, 212–219.  https://doi.org/10.1016/j.drugalcdep.2018.12.029.CrossRefPubMedGoogle Scholar
  49. Ruch, D. A., Sheftall, A. H., Schlagbaum, P., Rausch, J., Campo, J. V., & Bridge, J. A. (2019). Trends in suicide among youth aged 10 to 19 years in the United States, 1975 to 2016. JAMA Network Open, 2, e193886.  https://doi.org/10.1001/jamanetworkopen.2019.3886.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Ryan, S. A. (2018). Calculating the real costs of the opioid crisis. Pediatrics, 141(4), e20174129.CrossRefGoogle Scholar
  51. Salas, J., Scherrer, J. F., Schneider, F. D., Burroughs, T., Sullivan, M. D., Bucholz, K. K., …, Ahmedani, B. K. (2017). New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain, 158, 306–312.  https://doi.org/10.1097/j.pain.0000000000000763.CrossRefGoogle Scholar
  52. Salvy, S. J., Pedersen, E. R., Miles, J. N., Tucker, J. S., & D’Amico, E. J. (2014). Proximal and distal social influence on alcohol consumption and marijuana use among middle school adolescents. Drug and Alcohol Dependence, 144, 93–101.  https://doi.org/10.1016/j.drugalcdep.2014.08.012.CrossRefPubMedPubMedCentralGoogle Scholar
  53. Scherrer, J. F., Salas, J., Copeland, L. A., Stock, E. M., Ahmedani, B. K., Sullivan, M. D., …, Lustman, P. J. (2016). Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Annals of Family Medicine, 14, 54–62.  https://doi.org/10.1370/afm.1885.CrossRefGoogle Scholar
  54. Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review, 17, 275–297.  https://doi.org/10.1007/s11065-007-9031-0.CrossRefPubMedGoogle Scholar
  55. Sheridan, D. C., Laurie, A., Hendrickson, R. G., Fu, R., Kea, B., & Horowitz, B. Z. (2016). Association of overall opioid prescriptions on adolescent opioid abuse. The Journal of Emergency Medicine, 51, 485–490.  https://doi.org/10.1016/j.jemermed.2016.06.049.CrossRefPubMedPubMedCentralGoogle Scholar
  56. Silveira, M. L., Green, V. R., Iannaccone, R., Kimmel, H. L., & Conway, K. P. (2019). Patterns and correlates of polysubstance use among US youth aged 15–17 years: wave 1 of the Population Assessment of Tobacco and Health (PATH) Study. Addiction, 114, 907–916.  https://doi.org/10.1111/add.14547.CrossRefGoogle Scholar
  57. Skogen, J. C., Harvey, S. B., Henderson, M., Stordal, E., & Mykletun, A. (2009). Anxiety and depression among abstainers and low-level alcohol consumers. The Nord-Trondelag Health Study. Addiction, 104, 1519–1530.  https://doi.org/10.1111/j.1360-0443.2009.02659.x.CrossRefPubMedGoogle Scholar
  58. Smart, R. G. (1991). Crack cocaine use: A review of prevalence and adverse effects. The American Journal of Drug and Alcohol Abuse, 17, 13–26.  https://doi.org/10.3109/00952999108992806.CrossRefPubMedGoogle Scholar
  59. Sommers, I., Baskin, D., & Baskin-Sommers, A. (2006). Methamphetamine use among young adults: Health and social consequences. Addictive Behaviors, 31, 1469–1476.  https://doi.org/10.1016/j.addbeh.2005.10.004.CrossRefPubMedGoogle Scholar
  60. StataCorp. (2015). Stata Statistical Software: Release 14. College Station, TX: StataCorp LP.Google Scholar
  61. Substance Abuse and Mental Health Services Administration. (2018). Reports and detailed tables from the 2017 National Survey on Drug Use and Health. Retrieved from https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2017-NSDUH.
  62. Weyandt, L., Janusis, G., Wilson, K., Verdi, G., Paquin, G., Lopes, J., …, Dussault, C. (2009). Nonmedical prescription stimulant use among a sample of college students: Relationship with psychological variables. Journal of Attention Disorders, 13, 284-296.  https://doi.org/10.1177/1087054709342212.CrossRefGoogle Scholar
  63. Xu, J.Q., Murphy, S.L., Kochanek, K.D., Arias E. (2016). Mortality in the United States, 2015. (NCHS data brief, no 267). Retrieved from https://www.cdc.gov/nchs/data/databriefs/db267.pdf.
  64. Yarborough, B. H., Stumbo, S. P., Janoff, S. L., Yarborough, M. T., McCarty, D., Chilcoat, H. D., …, Green, C. A. (2016). Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis. Drug and Alcohol Dependence, 167, 49–56.  https://doi.org/10.1016/j.drugalcdep.2016.07.024.CrossRefGoogle Scholar
  65. Young, A., McCabe, S. E., Cranford, J. A., Ross-Durow, P., & Boyd, C. J. (2012). Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use. Journal of Addictive Diseases, 31, 332–341.  https://doi.org/10.1080/10550887.2012.735564.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of Social WelfareUniversity at Albany, SUNYAlbanyUSA
  2. 2.School of Social WorkEastern Michigan UniversityYpsilantiUSA

Personalised recommendations